Drug intelligence / Profile preview

StemStrength

Development stage: Unknown
Lead developer: Stemtech
Modality: Small Molecules
Administration: Oral

Overview

StemStrength is a multi-ingredient dietary supplement developed by Stemtech Corporation, marketed as a component of their stem cell nutrition product line. It is specifically formulated to support the body's natural renewal processes, with a focus on maintaining muscle and joint health and supporting the function of adult stem cells. The product contains a blend of vitamins, including Vitamin C and Vitamin D3, which provide antioxidant support and regulate cellular health, alongside a proprietary blend of botanical extracts such as *Aphanizomenon flos-aquae* (AFA) and *Undaria pinnatifida*. StemStrength is intended for oral consumption and is positioned as a nutritional adjunct to support physical performance, recovery, and overall cellular vitality.

Brand names: StemStrength

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on StemStrength.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on StemStrength.

Explore the full profile